REG - Feedback PLC - Further CDC Pilot Programme Secured

FeedbackAnnouncement

21/03/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240321:nRSU6705Ha&default-theme=true

RNS Number : 6705H  Feedback PLC  21 March 2024

Prior to publication, the information contained within this announcement was
deemed by the Company to constitute inside information as stipulated under the
Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of
this announcement, this information is now considered to be in the public
domain.

 

Feedback plc

 

Feedback secures CDC pathway pilot with Oldham CDC, part of the Northern Care
Alliance

 

·      Third CDC pilot site announced since December 2023

·      Focused on further demonstrating the impact of a pathway approach
on CDC utilisation and wider patient wait times

 

Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical
infrastructure specialist, announces that it has secured funding of £50,000
for a further Community Diagnostic Centre ("CDC") pathway pilot with the
Oldham CDC, run by the Northern Care Alliance. This follows the two pilot
sites, Amersham CDC in Buckinghamshire and a pan regional pilot across
Buckinghamshire, Oxfordshire and Berkshire ICS ("BOB ICS"), announced on 19
December 2023. The Company has contracted directly with Oldham CDC using an
additional award of funding locally disbursed for this purpose under NHS
England's ("NHSE"), CDC Programme.

 

The contract entered into this week reflects advisory services Feedback has
and continues to provide to Oldham CDC for the four-month period ended 31
March 2024 in relation to pathways development and deployment of the Company's
market leading symptom-based pathway tool, Bleepa.  On completion of the
initial milestones, the Company will support Oldham CDC to apply for more
funding from the 2024-25 NHS budget to extend the pilot with a view to
installing Bleepa and establishing a live breathlessness pathway for patients.
This will be used to complement findings from the ongoing pilots in Amersham
CDC and BOB ICS, and follows the success of the ongoing pilot at Queen
Victoria Hospital ("QVH") / Sussex Integrated Care System ("Sussex ICS") for
the breathlessness pathway.

 

The Company continues to focus on providing reference points for commercial
contracts and building the case for subsequent funding of a wider pathway
approach to CDC delivery.

 

Dr Tom Oakley, CEO of Feedback plc said: "We are gaining momentum in the CDC
space following the funding support released by NHSE. Each additional site
builds the evidence base for wider rollout and helps convince the wider NHS of
the unquestionable benefits of the symptom-based, straight-to-diagnostic
pathway approach.

 

"A national conversation is growing around how CDCs can be used to drive down
waitlists and demonstrates how the NHS can achieve a return on their capital
investments to date in building CDCs. This is about leveraging the diagnostic
outputs of the CDC to drive down waitlists by integrating them into patient
pathways.

 

"We are focused on further demonstrating the impact of a pathway approach on
CDC utilisation and wider patient wait times - by providing multiple service
lines and mutual aid delivery models for sharing workforce capacity at a
regional basis through the Bleepa platform. We continue to have a number of
discussions at the local, regional and national levels with NHS bodies and
anticipate further updates in the coming months.

 

"Furthermore, we are encouraged by the increased NHS spending announced in the
Spring Budget, highlighting the importance of investing in digital
capabilities for the UK healthcare system. It is essential that the UK has a
modern system that is able to provide timely care for patients - and we
believe that Bleepa could have an integral role to play."

 

 

 

--Ends--

Enquiries:

 

 Feedback plc                                    +44 (0) 20 3997 7634

 Tom Oakley, CEO                                 IR@fbk.com (mailto:IR@fbk.com)

 Anesh Patel, CFO

 Panmure Gordon (UK) Limited (NOMAD and Broker)  +44 (0)20 7886 2500

 Emma Earl/Freddy Crossley (Corporate Finance)

 Rupert Dearden (Corporate Broking)

 Walbrook PR Ltd;                                Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
                                                 (mailto:feedbackplc@walbrookpr.com)
 Nick Rome/Joe Walker                            07748 325 236 or 07407 020 470

 

 

About Feedback

 

Feedback plc helps clinical teams to make better decisions faster for
patients. We design products that enhance clinician access to patient data and
to their colleagues. Our unique approach centres around individual patient
episodes, into which we pull relevant clinical data from hospital systems and
around which we build remote clinical teams for collaboration. As a result, we
produce a digital infrastructure that makes patient data available to
clinicians in multiple settings, in a format that enables them to meaningfully
interact with it, providing flexibility to clinicians and free movement of
patients between provider settings - clinicians can practice from anywhere and
patients can attend any care provider for treatment.

 

Our products Bleepa and CareLocker work together to deliver unparalleled value
to our customers. Bleepa is our application layer and sits on top of
CareLocker as our data layer. Bleepa is a clinician facing platform that
displays clinical results from a patient's CareLocker at a certified and
regulated quality, that is suitable for clinical use and enables dialogue on a
patient-by-patient basis with colleagues through a secure, auditable chat
interface that links back to the patient medical record. The CareLocker data
storage model is built around the patient. Our vision is one where relevant
clinical data is always available to the patient as well as to any care
setting that they may attend - a federated data architecture with the patient
as the tenant.

 

The Company has a number of growth opportunities domestically and
internationally across a range of markets including the NHS, the veterinary
market and private healthcare providers and its highly scalable Software as a
Service ("SaaS")-based model is expected to provide increasing levels of
revenue visibility as the Company grows its customer base.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCKZGZFVGDGDZM